Papers/PMID:33594986
The impact of cholecalciferol on markers of vascular calcification in hemodialysis patients: A randomized placebo controlled study.
Nutrition, metabolism, and cardiovascular diseases : NMCD2021The record
1 finding · 1 compound · 1 endpoint
What it reported
How to read these marksWhat moved
1 finding
calciol — increases serum 25-hydroxyvitamin D concentration
Evidence strength: very limited.Findingreplicated ×33“Cholecalciferol significantly increased serum levels of 25(OH)D and fetuin-A in the treatment group (p-value < 0.001), while no significant difference was observed in the placebo group.”
Quoted verbatim from The impact of cholecalciferol on markers of vascular calcification in hemodialysis patients: A randomized placebo controlled study.. - Study
- RCT
- Dose
- 200,000 IU cholecalciferol per month, oral, for 3 months
- Population
- Hemodialysis patients
The impact of cholecalciferol on markers of vascular calcification in hemodialysis patients: A randomized placebo controlled study.2021PMID:3359498610.1016/j.numecd.2020.09.014Permalink